web analytics
t1
t8
t7
t3
t9

Welcome to Discuva

Discuva is a drug discovery company focused on the creation of Next Generation targeted antimicrobials against new emerging and drug-resistant bacterial pathogens.

From a study of 114 countries, the World Health Organisation has predicted a future where all current antibiotic drugs are ineffective. In this ‘post-antibiotic era’ a simple scratch or routine surgical procedure will be a potentially life-threatening event.

At Discuva, using ground-breaking new technologies, we are successfully developing completely new classes of antibiotics which we believe will play a major role in protecting society from the forthcoming threat promised by the emergence of drug-resistant bacteria.

Upcoming Events

Latest Tweets from @DiscuvaLtd

Discuva Ltd @DiscuvaLtd
RT @ppazaction: Untreatable #gonorrhea is here. The time to invest in #antibiotic research is NOW. https://t.co/XKNj1BszhI #SaveABX #superb
Discuva Ltd @DiscuvaLtd
RT @BSACandJAC: A new competition for 2018 will make up to £10 million available to UK organisations to work with Chinese partners #AMR htt…
Discuva Ltd @DiscuvaLtd
We all have the capacity to be experimental scientists. Let’s use it | Tom McLeish https://t.co/ADG4LBMYWp